about
Leishmania RNA virus: when the host pays the tollComparative genomic analysis of three Leishmania species that cause diverse human diseaseThe Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi InfectionRecent developments in drug discovery for leishmaniasis and human African trypanosomiasisMucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healingFirst-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimonyEffect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survivalCellular growth and mitochondrial ultrastructure of leishmania (Viannia) braziliensis promastigotes are affected by the iron chelator 2,2-dipyridylChemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensisDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Drought, smallpox, and emergence of Leishmania braziliensis in northeastern Brazil.American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics.Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil.Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva.Complexities of assessing the disease burden attributable to leishmaniasis.Development of a multilocus microsatellite typing approach for discriminating strains of Leishmania (Viannia) speciesCXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study.Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil.Leishmaniasis: a review.Cutaneous Manifestations of Human and Murine LeishmaniasisMucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.Molecular epidemiology for vector research on leishmaniasis.Facial structure alterations and abnormalities of the paranasal sinuses on multidetector computed tomography scans of patients with treated mucosal leishmaniasis.Cutaneous leishmaniasis in Cuban immigrants to Texas who traveled through the Darién Jungle, PanamaToward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensisAntigen-triggered interferon-γ and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease.Mucosal leishmaniasis and abnormalities on computed tomographic scans of paranasal sinusesTranscriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans.Cutaneous leishmaniasis in an immigrant Saudi worker: a case report.Oral manifestations in the American tegumentary leishmaniasis.Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.Association between HLA genes and American cutaneous leishmaniasis in endemic regions of Southern BrazilPolymerase chain reaction detection of Leishmania kDNA from the urine of Peruvian patients with cutaneous and mucocutaneous leishmaniasis.Laboratory diagnosis of visceral leishmaniasisA cluster of cutaneous leishmaniasis associated with human smugglingReappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune responseEvidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.Transforming growth factor-beta in human cutaneous leishmaniasisClinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review.Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis.
P2860
Q21131306-47AED0B3-3087-4937-8AEF-4AE73B88F651Q21972828-B2B43426-C2A5-408C-AED0-D80289366D02Q26829884-20E3E994-06F6-4308-A3B9-C5031D029296Q27011766-38580DD0-C1AC-44CE-AEEE-40CA3D082DCAQ28369371-D94A0705-2D03-4E1B-8586-6B64F41A3F28Q28475794-BDCE96C7-55F9-4D27-A45F-4828264A4FFDQ28478343-CF651CDE-303C-4479-8799-5E291AC2A410Q28534502-B5D123B5-17DB-4EA9-BC1D-F8C8DBFE0B7EQ28544030-96D1A3DE-D6AB-42C9-804E-5D60D86A0166Q30275257-8F8842A2-85D8-49DB-BBE4-53785D69B525Q30438890-2863C593-A675-4F8A-99C0-CF83FCC1B4E6Q31427105-4ABC70A6-BE37-4569-8ED1-879117BF75B5Q31796135-440807E3-3E16-4DFF-B0D3-B0075FDEE678Q33308759-76DDD6D6-72A4-4DC0-8428-7134E485221CQ33380173-34837400-C5D9-4A3D-BFE3-056E46156C01Q33479906-B7AC5DA7-E5E2-491A-A601-49E75A8DDF17Q33525373-AEC93787-F5EC-4A7F-8888-402870393555Q33739398-2E2E890E-16F0-467A-8327-8A25DD9C9653Q33777851-95724A02-5E79-480F-B426-F7C8F3CD4083Q33839048-E70708CF-90C8-4312-A615-2140A352E553Q33847397-1571D610-A0A6-4B33-985F-0C091BAB092BQ33858828-05E1E345-9FB1-4B9C-9CF6-D0536AE40D22Q33981782-EA250CC8-35EF-409F-98B7-1B17AA75563BQ34015961-F5A6FAFF-789B-4639-848A-054A5155B8C0Q34033888-F5F4BFD4-5919-4043-BA77-8ED2C9C9CE76Q34065388-92400A41-DE98-491A-B19B-73003C2D8C9CQ34087321-3B635255-BBAB-4A1B-8345-A11D9DA067B0Q34303377-A4564A44-2905-4F6A-B775-1FE8C72C94B9Q34439711-EF82D410-13FF-4073-8D26-FEA462236935Q34489065-159164EB-E38F-4723-B27A-BBA20CEEFF1BQ34574468-7E9BA433-0577-484E-80FA-5AE21BD27009Q34702872-CD0BF362-338D-488B-82E9-1188F5A13DA8Q34707789-0E2D0B1E-34CD-4A4E-BF49-39E0FD077C24Q34805276-B147F302-1DFD-4832-86B4-CF61A7A66CCFQ35031892-CF6DA2D1-185B-4384-A324-1E372775B3DEQ35168283-FA46EFC5-24A6-44A2-8316-57BB265A301FQ35249747-FF89A517-6407-440F-9FCF-43EF171C4759Q35798613-33F09641-BBE4-470D-A0B7-205EDB0090E4Q35845549-7CD472C6-3172-4BE9-AA26-642BE4FE3CEEQ35867155-F6A25EDE-4746-48D2-B3B1-53BB5BB0018D
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Mucosal leishmaniasis ("espundia" Escomel, 1911).
@en
Mucosal leishmaniasis ("espundia" Escomel, 1911).
@nl
type
label
Mucosal leishmaniasis ("espundia" Escomel, 1911).
@en
Mucosal leishmaniasis ("espundia" Escomel, 1911).
@nl
prefLabel
Mucosal leishmaniasis ("espundia" Escomel, 1911).
@en
Mucosal leishmaniasis ("espundia" Escomel, 1911).
@nl
P1476
Mucosal leishmaniasis ("espundia" Escomel, 1911).
@en
P2093
Marsden PD
P304
P356
10.1016/0035-9203(86)90243-9
P577
1986-01-01T00:00:00Z